These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 14971862

  • 21. Antipanic drug modulation of 35% CO2 hyperreactivity and short-term treatment outcome.
    Perna G, Bertani A, Caldirola D, Gabriele A, Cocchi S, Bellodi L.
    J Clin Psychopharmacol; 2002 Jun; 22(3):300-8. PubMed ID: 12006901
    [Abstract] [Full Text] [Related]

  • 22. Panic disorder: long-term pharmacotherapy and discontinuation.
    Rickels K, Schweizer E.
    J Clin Psychopharmacol; 1998 Dec; 18(6 Suppl 2):12S-18S. PubMed ID: 9872708
    [Abstract] [Full Text] [Related]

  • 23. Antidepressant efficacy and safety of low-dose sertraline and standard-dose imipramine for the treatment of depression in older adults: results from a double-blind, randomized, controlled clinical trial.
    Forlenza OV, Almeida OP, Stoppe A, Hirata ES, Ferreira RCR.
    Int Psychogeriatr; 2001 Mar; 13(1):75-84. PubMed ID: 11352337
    [Abstract] [Full Text] [Related]

  • 24. Long-term maintenance and discontinuation of imipramine therapy in panic disorder with agoraphobia.
    Mavissakalian MR, Perel JM.
    Arch Gen Psychiatry; 1999 Sep; 56(9):821-7. PubMed ID: 12884888
    [Abstract] [Full Text] [Related]

  • 25. Antidepressants in panic disorder.
    Jefferson JW.
    J Clin Psychiatry; 1997 Sep; 58 Suppl 2():20-4; discussion 24-5. PubMed ID: 9078990
    [Abstract] [Full Text] [Related]

  • 26. Sertraline in the treatment of panic disorder: a flexible-dose multicenter trial.
    Pollack MH, Otto MW, Worthington JJ, Manfro GG, Wolkow R.
    Arch Gen Psychiatry; 1998 Nov; 55(11):1010-6. PubMed ID: 9819070
    [Abstract] [Full Text] [Related]

  • 27. Are there differences by gender in response to pharmacotherapy for depression?
    Marsland TW, Newton W.
    J Fam Pract; 2000 Dec; 49(12):1149. PubMed ID: 11132066
    [No Abstract] [Full Text] [Related]

  • 28. Predictors of outcome in panic disorder: a 5-year prospective follow-up study.
    Scheibe G, Albus M.
    J Affect Disord; 1996 Nov 25; 41(2):111-6. PubMed ID: 8961038
    [Abstract] [Full Text] [Related]

  • 29. SSRIs vs. TCAs in the treatment of panic disorder: a meta-analysis.
    Bakker A, van Balkom AJ, Spinhoven P.
    Acta Psychiatr Scand; 2002 Sep 25; 106(3):163-7. PubMed ID: 12197851
    [Abstract] [Full Text] [Related]

  • 30. The treatment of panic disorder in a clinical setting: a 12-month naturalistic study.
    Marchesi C, Ampollini P, Signifredi R, Maggini C.
    Neuropsychobiology; 1997 Sep 25; 36(1):25-31. PubMed ID: 9211441
    [Abstract] [Full Text] [Related]

  • 31. Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.
    Foster RH, Goa KL.
    CNS Drugs; 1997 Aug 25; 8(2):163-88. PubMed ID: 23338224
    [Abstract] [Full Text] [Related]

  • 32. The treatment of chronic depression, part 1: study design and rationale for evaluating the comparative efficacy of sertraline and imipramine as acute, crossover, continuation, and maintenance phase therapies.
    Rush AJ, Koran LM, Keller MB, Markowitz JC, Harrison WM, Miceli RJ, Fawcett JA, Gelenberg AJ, Hirschfeld RM, Klein DN, Kocsis JH, McCullough JP, Schatzberg AF, Thase ME.
    J Clin Psychiatry; 1998 Nov 25; 59(11):589-97. PubMed ID: 9862605
    [Abstract] [Full Text] [Related]

  • 33. Selective serotonin reuptake inhibitors in the treatment of panic disorder and agoraphobia.
    Bakker A, van Balkom AJ, van Dyck R.
    Int Clin Psychopharmacol; 2000 Aug 25; 15 Suppl 2():S25-30. PubMed ID: 11110016
    [Abstract] [Full Text] [Related]

  • 34. Predictors of response to acute treatment of chronic and double depression with sertraline or imipramine.
    Hirschfeld RM, Russell JM, Delgado PL, Fawcett J, Friedman RA, Harrison WM, Koran LM, Miller IW, Thase ME, Howland RH, Connolly MA, Miceli RJ.
    J Clin Psychiatry; 1998 Dec 25; 59(12):669-75. PubMed ID: 9921701
    [Abstract] [Full Text] [Related]

  • 35. SSRIS versus tricyclic antidepressants in depressed inpatients: a meta-analysis of efficacy and tolerability.
    Anderson IM.
    Depress Anxiety; 1998 Dec 25; 7 Suppl 1():11-7. PubMed ID: 9597346
    [Abstract] [Full Text] [Related]

  • 36. The treatment of chronic depression, part 3: psychosocial functioning before and after treatment with sertraline or imipramine.
    Miller IW, Keitner GI, Schatzberg AF, Klein DN, Thase ME, Rush AJ, Markowitz JC, Schlager DS, Kornstein SG, Davis SM, Harrison WM, Keller MB.
    J Clin Psychiatry; 1998 Nov 25; 59(11):608-19. PubMed ID: 9862607
    [Abstract] [Full Text] [Related]

  • 37. Chronic depression and comorbid personality disorders: response to sertraline versus imipramine.
    Russell JM, Kornstein SG, Shea MT, McCullough JP, Harrison WM, Hirschfeld RM, Keller MB.
    J Clin Psychiatry; 2003 May 25; 64(5):554-61. PubMed ID: 12755659
    [Abstract] [Full Text] [Related]

  • 38. Three year naturalistic outcome study of panic disorder patients treated with paroxetine.
    Dannon PN, Iancu I, Cohen A, Lowengrub K, Grunhaus L, Kotler M.
    BMC Psychiatry; 2004 Jun 11; 4():16. PubMed ID: 15191617
    [Abstract] [Full Text] [Related]

  • 39. The use of the Panic and Agoraphobia Scale in a clinical trial.
    Bandelow B, Brunner E, Broocks A, Beinroth D, Hajak G, Pralle L, Rüther E.
    Psychiatry Res; 1998 Jan 16; 77(1):43-9. PubMed ID: 10710174
    [Abstract] [Full Text] [Related]

  • 40. Sertraline treatment of panic disorder: results of a long-term study.
    Rapaport MH, Wolkow R, Rubin A, Hackett E, Pollack M, Ota KY.
    Acta Psychiatr Scand; 2001 Oct 16; 104(4):289-98. PubMed ID: 11722304
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.